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The global atlas of podoconiosis
The world stands on the edge of an historic public 
health success with the imminent eradication of 
dracunculiasis (guinea-worm disease) and polio. Since 
the World Health Assembly called for the eradication 
of dracunculiasis in 19861 and poliomyelitis in 1988,2 
astonishing progress has been made. In 2016, only 
25 human cases of dracunculiasis were reported from 
three countries,3 transmission of wild poliovirus was 
found in only three countries, and 37 cases of polio were 
reported worldwide.4 In addition to these achievements, 
there has been progress in the elimination of the little-
known disease podoconiosis (endemic non-filarial 
elephantiasis).5 Essential to this elimination effort is 
the need to understand the geography of the disease to 
identify potentially at-risk areas and set a benchmark for 
evaluating elimination efforts.6 
The global burden of podoconiosis is not at 
present clearly defined, although available estimates 
suggest that globally there are 4 million people with 
podoconiosis,7 mainly in tropical countries of Africa, 
Central and South America, and southeast Asia. Tropical 
African countries bear the highest disease burden. A 
literature search identifies 32 countries as being either 
known or suspected to be endemic for podoconiosis. In 
Africa, the disease has been reported in Angola, Burundi, 
Cameroon, Cape Verde, Chad, Democratic Republic of 
Congo, Equatorial Guinea, Ethiopia, Kenya, Madagascar, 
Mozambique, Niger, Nigeria, Rwanda, São Tomé and 
Príncipe, Sudan, Tanzania, and Uganda. Podoconiosis 
has been reported in the Latin American highlands 
in Brazil, Colombia, Costa Rica, Ecuador, El Salvador, 
French Guiana, Guatemala, Honduras, Mexico, Peru, 
and Suriname. In Asia, although filarial elephantiasis 
predominates in India, podoconiosis has been reported 
in the northwestern part of the country, as well as in 
Sri Lanka and Indonesia.8 However, under-reporting 
of podoconiosis is possible because of diagnostic 
challenges and a low index of suspicion. Podoconiosis 
is an environment-related disease, caused by long-
term barefoot exposure to red clay soil.6,9,10 Therefore, 
environmental factors, such as soil, and other climatic 
factors that affect the generation of soil, can help 
predict the occurrence of podoconiosis. An individual’s 
vulnerability to the disease is also aggravated by poverty 
and insufficient access to water for foot hygiene.11
We have received funding from the Wellcome 
Trust12 to develop a global atlas of podoconiosis. We 
aim to advance new knowledge on the geographical 
distribution and spatial epidemiology of the disease. A 
first step in this work will be to establish the geographical 
absence of disease by applying an evidence consensus 
approach (thorough literature searches and contacting 
ministries of health).13,14 The project will also use 
environmental predictors to determine environmental 
suitability for the occurrence of podoconiosis. In our 
previous work in Ethiopia we have identified important 
covariates that drive the spatial distribution of 
podoconiosis. Using boosted regression tree modelling, 
we mapped the environmental limits of podoconiosis, 
with high accuracy for determining the presence or 
absence of podoconiosis.6 Once validated in other 
countries this model will have the potential to define 
the environmental limits of podoconiosis globally, thus 
targeting survey efforts to high-priority countries.
Population-based surveys are important sources of 
data for mapping of podoconiosis.15 Surveys informed 
by podoconiosis risk stratification will also be important. 
Such surveys will provide statistically powered and 
spatially representative sampling, which will capture 
environmental risk drivers of podoconiosis within a 
Panel: Standard podoconiosis survey
Podoconiosis surveys are done in individuals aged 15 years or 
older who have lived in the implementation unit 
(administrative units used as the basis for making decisions 
about morbidity management) for more than 10 years.15 
Podoconiosis is a clinical diagnosis based on exclusion of 
other potential causes of lymphoedema and disease-specific 
tests, such as the Alere Filariasis Test Strip and Wb123 test, to 
exclude lymphoedema due to lymphatic filariasis. For the 
surveyed cluster or districts, the following data are required:
•	 The	name	of	the	site	(district	or	village	names)	
•	 Region	and	district	where	the	survey	was	done	
•	 Coordinates	(longitude	and	latitude)	of	community	or	
cluster (if available)
•	 Survey	methods	and	population	sampling
•	 Year	of	survey
•	 Age	range
•	 Number	of	individuals	examined
•	 Number	of	people	with	lymphoedema
•	 Number	of	people	diagnosed	with	podoconiosis	
•	 Disease	stage	for	podoconiosis16
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country. A recommended survey of podoconiosis is done 
among individuals aged 15 years or older (podoconiosis 
commonly occurs after the age of 15 years), with a clear 
diagnostic algorithm using history, physical diagnosis, 
and disease-specific tests (panel).15 The usefulness of 
the data can be enhanced by Bayesian modelling to 
identify risk factors at different scales and to predict the 
prevalence and burden of podoconiosis in unsampled 
locations. Such a Bayesian framework has been used 
to effectively map the global distribution of several 
infectious diseases, including malaria, dengue virus 
infection, and soil-transmitted helminth infection.14,17
Data collected through dedicated epidemiological 
surveys can be expensive and inefficient, however, 
especially for countries with low disease prevalence. To 
reduce reporting costs, suspected endemic countries 
can also collect information about podoconiosis 
through routine surveillance systems. For example, 
since Ethiopia included podoconiosis into the national 
health management information system in 2013, an 
increased number of cases have been reported. The 
use of community health workers to identify cases of 
podoconiosis, which are subsequently validated by 
experienced health workers, has been piloted with 
good success.18,19 There is also opportunity for the 
integrated reporting of morbidity cases due to other 
neglected tropical diseases, such as leprosy, Buruli ulcer, 
and trichiasis, and subsequent management through 
the primary health-care system. Clinical diagnosis of 
podoconiosis based on pathognomonic signs and 
symptoms has been found to be workable in the regular 
health system. Case definitions for podoconiosis have 
been developed and can be used for case identification 
through routine surveillance.5,20
Over the span of 5 years, the global atlas of 
podoconiosis will define the epidemiology and 
distribution of podoconiosis globally. Through 
collection and collation of the available evidence, 
generation of new epidemiological data, and the 
currently available state of the art geostatistical and 
machine learning approaches, the global limits of 
podoconiosis will be defined and the population at 
risk and burden of the disease estimated for the first 
time. Further collaborations from endemic countries, 
partners, and WHO country offices are crucial to advance 
the project goals. Additionally, we are exploring 
strategies to integrate podoconiosis mapping with 
ongoing mapping of other neglected tropical diseases. 
The atlas will provide vital evidence of the geographical 
distribution and burden of podoconiosis globally, and 
provide an important basis for expanding prevention 
and treatment services on the path towards a world 
without podoconiosis. 
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